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 2 
ABSTRACT 1 
The fosABCDXE operon encodes components of a putative fructose/mannose 2 
phosphoenolpyruvate-dependent phosphotransferase system (PTS) and a β-3 
fructosidase precursor (FosE) that are involved in the fructooligosaccharide (FOS) 4 
utilization pathway of Lactobacillus paracasei 1195.  The presence of an N-terminal 5 
signal peptide sequence and a LPQAG cell wall anchor motif at the C-terminal region of 6 
the deduced FosE precursor amino acid sequence predicted that the enzyme is cell 7 
wall-associated, indicating that FOS may be hydrolyzed extracellularly.  In this study, 8 
cell fractionation experiments demonstrated that the FOS hydrolysis activity was 9 
contained exclusively in the cell wall extract of L. paracasei previously grown on FOS.  10 
In contrast, no measurable FOS hydrolysis activity was detected in the cell wall extract 11 
from the isogenic fosE mutant.  Induction of β-fructosidase activity was observed when 12 
cells were grown on FOS, inulin, sucrose, or fructose, but not glucose.  A diauxic growth 13 
pattern was observed when cells were grown on FOS in the presence of limiting 14 
glucose (0.1%).  Analysis of the culture supernatant revealed that glucose was 15 
consumed first, followed by the longer chain FOS species.  Transcription analysis 16 
further showed that the fos operon was expressed only after glucose was depleted in 17 
the medium.   Expression of fosE in a non-FOS-fermenting strain, Lactobacillus 18 
rhamnosus GG, enabled the recombinant strain to metabolize FOS, inulin, sucrose, and 19 
levan.  20 
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INTRODUCTION 1 
The consumption of fermented food products or dietary supplements containing 2 
probiotic species of Lactobacillus and Bifidobacteria has been suggested to promote 3 
gastrointestinal (GI) health in humans and other animals by increasing the population of 4 
these microorganisms in the GI tract (10, 40).  However, the beneficial effects of these 5 
bacteria may be transient due to colonization resistance by the commensal microbiota, 6 
which restricts the ability of probiotic bacteria to become well established in the 7 
intestinal environment (3, 15).  An approach to overcome this limitation is to include 8 
prebiotics in the host diet.  Prebiotics are specific nondigestible dietary sugars that are 9 
selectively metabolized by certain probiotic bacteria and that enhance their survival and 10 
colonization in the GI tract (12).  Such an approach would also enrich the population of 11 
indigenous bifidobacteria and lactobacilli, allowing them to occupy a more dominant 12 
position in the gut ecosystem.     13 
Fructooligosaccharides (FOS) are among the prebiotic substances that have 14 
been shown to selectively stimulate the growth and activity of certain strains of 15 
Lactobacillus and Bifidobacterium (4, 11, 13, 16, 47).  Two types of FOS, that differ 16 
based on their methods of preparation, are commercially available and are widely used 17 
in food.  One type, referred to as the GFn-type of FOS, is enzymatically produced from 18 
sucrose, and consists of a glucose monomer (G) linked α-1,2 to two or more β-2,1-19 
linked fructose units (F), forming a mixture of GF2, GF3, and GF4 (16, 17).  The other 20 
type of commercial FOS is produced by partial enzymatic hydrolysis of the fructan 21 
polymer, inulin.  The resulting product consist of a mixture of linear fructose oligomers, 22 
in the FFn form, also linked β-2,1, and having a degree of polymerization varying from 2 23 
ACC
EPT
ED
 4 
to 10.  Due to the presence of a terminal glucose on the inulin molecule, the latter 1 
products also contain oligosaccharide species in the GFn form (6). 2 
Despite considerable commercial and research interests on the beneficial effects 3 
of FOS, the molecular basis for FOS metabolism by probiotic bacteria and specific 4 
members of the intestinal microflora has only recently been examined.  It now appears, 5 
however, that utilization of FOS occurs via one of two metabolic routes.  Either the 6 
substrate is transported intact and is hydrolyzed in the cytoplasm, or it is hydrolyzed by 7 
extracellular enzymes, followed by subsequent accumulation of the hydrolysis products.  8 
In Lactobacillus acidophilus NCFM, for example, the FOS metabolic pathway is 9 
encoded by a multiple sugar metabolism (msm) operon that resembles the msm operon 10 
of Streptococcus mutans and the raffinose (raf) operon of Streptococcus pneumoniae 11 
(1).  The msm operon encodes an ATP-dependent binding cassette (ABC)-type 12 
transport system and a cytoplasmic β-fructosidase that mediate FOS uptake and 13 
intracellular hydrolysis.  Expression of the operon was inducible by sucrose and FOS, 14 
but not glucose or fructose.  Similarly, cytoplasmic β-fructofuranosidases from 15 
Bifidobacterium adolescentis, B. infantis, and B. lactis have also been reported to 16 
hydrolyze FOS (9, 19, 20, 34-36, 46).  Although FOS transport in bifidobacteria has not 17 
been reported, the presence of at least seven gene loci encoding oligosaccharide 18 
transport and metabolism in the genome sequence of B. longum (44) suggests that 19 
uptake of FOS may also be mediated by specific oligosaccharide transporters.  In 20 
contrast, extracellular enzymes that hydrolyze FOS have also been reported for non-21 
intestinal bacteria, including a fructan β-fructosidase from Lactobacillus pentosus, and 22 
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 5 
levanbiohydrolases from Streptomyces exfoliatus and Microbacterium laevaniformans 1 
(39, 41, 45). 2 
 Recently, microarray expression analyses of Lactobacillus paracasei 1195 grown 3 
on FOS led to the identification of a putative fos operon that plays a major role in the 4 
FOS utilization pathway (14).  The fosABCDXE operon encodes a putative 5 
fructose/mannose PTS (FosABCDX) and a β-fructosidase precursor (FosE) that has 6 
high sequence identity with the putative levanase (lev) operons of Lactobacillus casei 7 
strains ATCC 334 and BL23.  Inactivation of the fosE gene led to the inability of the 8 
mutant strain to grow on FOS and other β-fructose-linked sugars.  The deduced amino 9 
acid sequence of FosE contains an N-terminal signal peptide sequence and a LPQAG 10 
cell wall anchor motif at the C-terminal region, suggesting that FOS may be hydrolyzed 11 
extracellularly by FosE, with the subsequent uptake of the hydrolysis products mediated 12 
by the FosABCDX PTS.  Microarray analyses also indicated that expression of the 13 
FOS-induced genes was subject to catabolite regulation by glucose (14).  Hence, the 14 
objectives of this study were to establish the location of the FOS hydrolysis activity in L. 15 
paracasei 1195 and to examine the effect of glucose on FOS utilization by L. paracasei.  16 
Additionally, we established the functional role of the fos operon by expressing the fosE 17 
gene in Lactobacillus rhamnosus GG, a widely used probiotic strain that has a limited 18 
ability to metabolize FOS (21) and other β-fructose-linked carbohydrates. 19 
 20 
MATERIALS AND METHODS 21 
Bacterial strains and growth conditions.  Strains and plasmids used in this study are 22 
listed in Table 1.  Parental strains of L. paracasei 1195 and L. rhamnosus GG were 23 
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routinely grown in MRS broth (Difco, Inc., Ann Arbor, MI) at 37°C in ambient 1 
atmosphere under static condition, and recombinant strains were grown in MRS 2 
medium containing 5 µg/ml of erythromycin (Erm).  For growth and enzyme experiments, 3 
cells were grown in modified MRS (mMRS) basal medium (14), supplemented with 4 
filter-sterilized solutions of FOS of the GFn (GTC Nutrition, Westminster, CO) or the FFn 5 
type (Orafti North America, Malvern, PA), glucose (Sigma-Aldrich, St. Louis, MO), 6 
fructose (Sigma), or sucrose (Sigma), at the indicated concentrations.  Inulin- or levan-7 
containing mMRS was prepared by addition of inulin (Sigma) or levan (Sigma) into 8 
mMRS prior to heat sterilization of the culture medium.  For diauxie experiments, L. 9 
paracasei 1195 were grown in semi-defined medium (SDM) (23) containing (per liter): 10 
10 g Bacto casitone (Difco), 5 g yeast nitrogen base (Difco), 1 g polysorbate 80 (Fisher 11 
Chemicals, Fairlawn, NJ), 2 g ammonium citrate (Sigma), 5 g sodium acetate (Sigma), 12 
0.1 g magnesium sulfate (Sigma), 0.05 g manganese sulfate (Sigma), 2 g dipotassium 13 
phosphate (MCB Manufacturing Chemists, Norwood, OH), and supplemented with 0.1% 14 
(wt/vol) glucose, 0.35% (wt/vol) FOS (GFn form), or 0.1% glucose plus 0.35% FOS.  15 
Escherichia coli DH5α, used as host for routine cloning procedures, was grown in Luria-16 
Bertani (LB) medium or Brain Heart Infusion (BHI) medium at 37°C with aeration at 200 17 
rpm.  When necessary, Erm was added at final concentrations of 250 µg/ml and 450 18 
µg/ml for BHI and LB media, respectively. 19 
DNA isolation and manipulations.  Isolation of genomic DNA from L. rhamnosus GG 20 
was performed as previously described for L. paracasei (14).  Plasmid DNA from E. coli 21 
was isolated using Zyppy Plasmid Miniprep I Kit (Zymo Research Corp., Orange, CA) 22 
according to the manufacturer’s recommendations.  Restriction enzymes (New England 23 
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Biolabs Inc., Ipswich, MA, and Takara Mirus Bio Inc., Madison, WI) were used as 1 
recommended by manufacturers.  DNA ligation was performed using Fast-Link DNA 2 
Ligation Kit (Epicentre Biotechnologies, Madison WI) according to supplied instructions.  3 
PCR amplicons were generated using Easy-A High Fidelity PCR cloning enzyme or 4 
PfuTurbo DNA polymerase (Stratagene Corp., La Jolla, CA) in an Amplitron II 5 
Thermolyne thermocycler (Barnstead/Thermolyne Corp., Dubuque, IA).  Primers were 6 
synthesized by Sigma-Genosys (The Woodlands, TX).  The PCR products were 7 
electrophoresed in 0.8% agarose gel, and DNA fragments were purified using 8 
Zymoclean Gel DNA Recovery Kit (Zymo Research) prior to downstream applications.  9 
DNA sequencing was performed by the Genome Core Research Facility (University of 10 
Nebraska, Lincoln, NE). 11 
For electroporation, E. coli cells were prepared according to protocols of the Wolf 12 
Laboratory (http://www.research.umbc.edu/%7Ejwolf/m7.htm).  Electroporation was 13 
performed in pre-chilled 0.2-cm electroporation cuvettes (Boca Scientific Inc., Boca 14 
Raton, FL) using a Gene Pulser electroporation system (Bio-Rad Laboratories, Inc., 15 
Hercules, CA) set at 12.5 kV cm-1, 200 Ω, and 25 µF.  Electrotransformation of L. 16 
rhamnosus GG were performed as previously described (14).  Briefly, stationary-phase 17 
cells were used to inoculate 100 ml of MRS broth (2% inoculum) and grown for 3 hrs 18 
(optical density at 625 nm ∼ 0.1 to 0.2).  Then, freshly prepared filter-sterilized penicillin 19 
G solution was added to a final concentration of 10 µg/ml, and the culture was grown for 20 
additional 1.5 to 2.0 hrs.  Cells were harvested at 5,500 x g for 15 min at 4°C, washed 21 
with 10 ml and 50 ml of ice-cold filter-sterilized 1X PEB buffer (per liter: 272 mM sucrose, 22 
1 mM MgCl2, 7mM potassium phosphate [KPO4], pH 7.4) sequentially, followed by a 23 
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 8 
third wash with 10 ml of ice-cold 10% (vol/vol) glycerol, and finally resuspended in 1 ml 1 
of 10% glycerol.  For electroporation, ∼ 0.1 µg of DNA was added to 50 µl of the cells, 2 
and the mixture was transferred into a pre-chilled 0.2-cm electroporation cuvette, and 3 
incubated on ice for 2 min.  Cells were electroporated at 12.5 kV cm-1, 400 Ω, and 25 µF 4 
and placed on ice immediately.  Transformed cells were supplemented with 950 µl of 5 
MRS broth and recovered for 3 to 4 hrs at 37°C.  Cells were then plated onto MRS agar 6 
containing 2.5 to 5.0 µg/ml of Erm and incubated at 37°C for 48 to 72 hrs under ambient 7 
atmospheric condition.   8 
Purification of L. paracasei total RNA.  Total RNA was isolated as previously 9 
described (14) using TRI Reagent (Molecular Research Center, Inc., Cincinnati, OH).  10 
The RNA samples were subsequently treated with DNase I using Turbo DNAfree kit 11 
(Ambion Inc., Austin, TX).  The quality and integrity of RNA samples were assessed 12 
spectrophotometrically (A260/A280 1.6 to 1.9) and gel electrophoresis, as described 13 
previously (14).  14 
FOS hydrolysis assay.  Lactobacillus paracasei 1195 and the BHe mutant strain were 15 
grown in mMRS broth containing 1% FOS (GFn form), and harvested by centrifugation 16 
at 3,000 x g for 15 min at room temperature when the OD625 nm reached 0.60 and 0.35, 17 
respectively.  Culture supernatants were filter-sterilized through 0.45 µm filters and 18 
concentrated to 1/20 of the initial volume using Amicon Ultra-4 centrifugal filter units 19 
(30,000 MWCO; Millipore Corp., Bedford, MA).  Cell pellets were washed twice in 0.1 M 20 
potassium phosphate buffer (pH 6.6) and resuspended in 1 ml of the same buffer.  The 21 
cell suspension was transferred into 1.5 ml conical tubes (BioSpec Products, Inc., 22 
Bartlesville, OK) containing 400 mg of 0.1 mm diameter glass beads (BioSpec 23 
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Products), and cells were disrupted by homogenization using a Mini-Beadbeater 1 
(BioSpec Products) at 4,200 rpm for 6 cycles of 1 min, with 1 min on ice between each 2 
interval.  Cell lysates were transferred into fresh tubes, and the fraction containing cell 3 
wall fragments was separated from the cytoplasmic extract by centrifugation at 13,800 x 4 
g for 10 min at room temperature.  This cell wall fraction was resuspended in 1 ml of 5 
phosphate buffer, whereas the cytoplasmic extract was concentrated to 1/5 of initial 6 
volume using Amicon Ultra-4, as described above. 7 
For induction experiments, L. paracasei 1195 was sub-cultured twice in mMRS 8 
containing 1% FOS (separately, in both GFn  and FFn types), sucrose, inulin, fructose, 9 
glucose, or 0.5% levan.  The cultures were subsequently used to inoculate (2% 10 
inoculum) 30 ml of mMRS containing the respective sugars at the same concentrations.  11 
When the OD625 nm reached 0.6 to 0.7, the cells were collected by centrifugation at 12 
3,000 x g for 20 min at 4°C.  Cell fractionation was performed as described above. 13 
For all β-fructosidase assays, 10 µl of the concentrated culture supernatant, cell wall 14 
fraction, or cytoplasmic extract was added to 190 µl of 1% (wt/vol) FOS (GFn or FFn 15 
type), sucrose, or inulin solution.  Reaction mixtures were incubated at 37°C for 3 hrs 16 
and inactivated by boiling for 2 min, and activities were reported as the amount of 17 
fructose released per minute per mg of protein.  Fructose concentrations were 18 
determined by using a Fructose Assay Kit (Sigma), according to the manufacturer’s 19 
instructions or by HPLC using an Aminex HPX-42C column (Bio-Rad Laboratories) and 20 
a RI 410 reflective index detector.  The internal and external temperatures of the column 21 
were maintained at 40°C and 85°C, respectively, with a column heater.  Water was 22 
used as mobile phase with a flow rate of 0.6 ml/min.  Protein concentrations were 23 
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determined by the Bradford Reagent (Sigma), based on the manufacturer’s 1 
specifications.  All experiments were done in duplicate. 2 
Lactate dehydrogenase (LDH) assay.  Samples of cell-free culture supernatant, cell 3 
wall extract and cytoplasmic extract were assayed for LDH activity as previously 4 
described (18).  Briefly, the reaction mixtures contained 1 ml of 0.1 M triethanolamine-5 
hydrochloride (pH 7.5), 80 µl of 0.1 M sodium pyruvate, 40 µl of 30 mM fructose-1,6-6 
diphosphate, 40 µl of freshly prepared 4 mM NADH, and 40 µl of each cell fraction or 7 
the culture supernatant.  The decrease in absorbance at 340 nm was recorded over 6 8 
minutes and used to calculate LDH activity. 9 
Catabolite repression studies.  Overnight cultures of L. paracasei, grown in SDM 10 
containing 1% FOS (GFn), were used to inoculate 1.2 liter of SDM containing 0.1% 11 
glucose, 0.35% FOS (GFn), or 0.1% glucose plus 0.35% FOS (GFn).  Cultures were 12 
incubated at 37°C in ambient atmosphere under static condition.  At various times, the 13 
cell densities were recorded, and portions of cultures grown were centrifuged and cell 14 
supernatants saved for analysis.  In addition, cells grown on SDM-0.1% glucose + 15 
0.35% FOS were centrifuged at 3,000 x g for 10 min at room temperature for isolation of 16 
total RNA.  To prepare RNA samples for gel electrophoresis on formaldehyde gel, 30 µg 17 
of each sample in 10 µl was mixed with 2.5 µl of 10X MOPS (0.2 M MOPS, 80 mM 18 
sodium acetate, 10 mM EDTA; pH 7.0), 3 µl of formaldehyde solution (Fisher [37% 19 
vol/vol]), 12.5 µl of formamide, and 1 µl of 1 mg/ml ethidium bromide.  The mixtures 20 
were incubated at 65°C for 10 min, chilled on ice for 2 to 3 min, followed by 21 
electrophoresis on a formaldehyde gel (1% agarose, 0.66 M formaldehyde, 1X MOPS).  22 
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The RNA was subsequently transferred onto Zeta-Probe blotting membrane (Bio-Rad 1 
Laboratories) using standard procedures (42).  The membrane was then soaked in 2X 2 
SSC (1X SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 5 min, and RNA was 3 
subsequently immobilized on the wet membrane by UV-crosslinking twice at 120,000 4 
µJoules in a Stratalinker Crosslinker (Stratagene).  The internal region of fosE gene 5 
(981 bp) used for synthesis of hybridization probe was amplified from L. paracasei 1195 6 
genomic DNA using fosE-for1 and fosE-rev1 primers (Table 1) in a 50 µl reaction 7 
containing 1 µl of 10 mM dNTP mix, 0.5 µg of genomic DNA, 2.5 U of Taq DNA 8 
polymerase, and 25 pmol of each primer in 1X Taq DNA polymerase buffer (Stratagene).  9 
PCR amplification was carried out in the following condition: 1 cycle at 95°C for 3 min, 10 
30 cycles of 30 sec at 95°C, 30 sec at 55°C, 1 min at 72°C, and a final cycle at 72°C for 11 
10 min.  Synthesis of DIG-labeled fosE probe with the fosE PCR product, hybridization, 12 
and detection of hybridized signals were performed using the DIG High Prime DNA 13 
Labeling and Detection Starter Kit II (Roche Diagnostics Corp., Indianapolis, IN) as 14 
described by manufacturer.  Hybridization signals were exposed onto X-Omat Blue XB-15 
1 imaging films (Gold Biotechnology, Inc., St. Louis, MO) in multiple exposure times (2 16 
to 8 min) to obtain optimum signal strength. 17 
Sugar analyses.  Glucose concentration in culture supernatants was measured using a 18 
YSI 2700 SELECT Biochemistry Analyzer (YSI Incorp., Yellow Springs, OH) equipped 19 
with glucose membranes (YSI 2365).  To determine the concentration of each FOS 20 
fraction in the culture supernatants, the samples along with FOS standards (0.05%, 21 
0.1%, 0.2%, and 0.4%) were spotted onto 20 x 20 cm thin layer chromatography (TLC) 22 
silica gel plates (Whatman Ltd., Kent, UK).  The plates were developed twice in acetic 23 
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acid-chloroform-water (7:5:1) solvent.  Spots were visualized by spraying plates with 1 
ethanolic 50% sulfuric acid, and heated at 115 °C for 5 min.  The TLC plates were 2 
subsequently scanned on a Epson Perfection 1660 Photo scanner (Epson America, Inc., 3 
Long Beach, CA), and density of spots on the scanned image was analyzed using the 4 
Scion Image for Windows software 5 
(http://www.scioncorp.com/frames/fr_download_now.htm). 6 
Expression of the L. paracasei β-fructosidase gene in L. rhamnosus GG.  To 7 
introduce the fosE gene into L. rhamnosus GG, a fragment containing the fosE gene 8 
with its native ribosomal binding sequence (RBS) and a promoter sequence isolated 9 
from L. rhamnosus GG, P-GL1 (33), were sequentially cloned into the pTRKH2 shuttle 10 
vector (38).  Briefly, the 4,131-bp fosE gene was PCR-amplified from the genomic DNA 11 
of L. paracasei 1195 using fosE-for2 and fosE-rev2 primers (Table 1).  The fosE 12 
amplicon was digested with XhoI and PstI, ligated into pTRKH2 with compatible ends, 13 
and transformed into E. coli DH5α.  The recombinant plasmid, designated as pRH5, 14 
was verified by restriction digest and sequencing.  Next, the P-GL1 promoter and the 15 
RBS for the fosE gene were cloned upstream of the fosE gene in the pRH5 plasmid.  16 
The P-GL1 promoter region was PCR-amplified from L. rhamnosus GG genomic DNA 17 
using PGL1-for and PGL1-rev primers (Table 1), with the fosE RBS incorporated into 18 
the latter primer.  The 103-bp PCR amplicon was restricted with EcoRV and XhoI, and 19 
ligated into similarly digested pRH5.  The ligation products were purified using DNA 20 
Clean & Concentrator-5 kit (Zymo Research) and transformed into E. coli DH5α.  21 
Ligation of the PGL-1 promoter and the fosE RBS upstream of fosE gene in the 22 
recombinant plasmid, designated as pYG582, was confirmed by DNA sequencing.  The 23 
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recombinant plasmid pYG582 was subsequently electroporated into L. rhamnosus GG, 1 
and transformants were recovered on MRS plates containing 2 to 5 µg/ml of Erm after 2 
incubation at 37°C in ambient atmosphere for 48 to 72 hrs.  The L. rhamnosus GG 3 
transformants harboring pYG582 were streaked on mMRS-1% FOS agar containing 5 4 
µg/ml Erm and 100 mg/L bromcresol purple to determine their ability to ferment FOS.  5 
One recombinant isolate that formed a yellow zone as a result of acid production from 6 
fermentation of FOS was selected and designated as L. rhamnosus GGE582.  The 7 
presence of pYG582 in the GGE582 strain was verified by direct cell PCR method 8 
essentially as described previously (5).  For phenotypic analysis, strains of GG and 9 
GGE582 were grown in mMRS and mMRS containing 5 µg/ml of Erm, respectively, and 10 
supplemented with 1% of glucose, fructose, sucrose, FOS (both types), inulin, or 0.5% 11 
levan. 12 
 13 
RESULTS 14 
Location of β-fructosidase activities in L. paracasei 1195.  To identify the location of 15 
the β-fructosidase activity in L. paracasei 1195, cells grown in mMRS broth containing 16 
1% FOS (GFn type) were harvested, and three fractions, representing the concentrated 17 
culture supernatant, crude cell wall extract, and cytoplasmic extract, were prepared as 18 
described above.  The same fractions were also obtained from the mutant strain, BHe.  19 
Using FOS (GFn type) as the substrate, the β-fructosidase activity of the wild type strain 20 
was detected almost exclusively in the cell wall extract (Table 2).  In contrast, FOS 21 
hydrolysis activity in the culture supernatant or the cytoplasmic extracts was negligible, 22 
relative to that in the cell wall extract.  No FOS hydrolysis activity was detected in the 23 
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BHe strain.  To confirm that the cell fractionation procedure had adequately separated 1 
the different fractions, all cell fractions and supernatants were assayed for LDH, a 2 
cytoplasmic marker enzyme.  As expected, LDH activity was detected only in the 3 
cytoplasmic extract (data not shown). 4 
Induction of β-fructosidase activity during growth on various sugars.  The 5 
influence of various carbohydrate growth substrates on the induction of β-fructosidases 6 
and their substrate specificities was examined (Fig. 1).  Regardless of the carbohydrate 7 
source in the media, β-fructosidase activities were only present in the cell wall extracts.  8 
Cells grown on inulin resulted in the highest enzyme activities, followed by cells grown 9 
in both types of FOS.  The two FOS products (GFn and FFn) and inulin also served as 10 
the preferred substrates.  In contrast, sucrose- and fructose-grown cells had the lowest 11 
activities, and only when FOS was the substrate.  Sucrose was the least preferred 12 
substrate, even for sucrose-grown cells.  No β-fructosidase activity was detected from 13 
the cell wall extract of glucose-grown cells, indicating that the enzyme was either not 14 
induced or repressed in the presence of glucose.  Analysis of the FOS (GFn) hydrolysis 15 
products by HPLC showed that fructose and sucrose were the major products from FOS 16 
hydrolysis.  Inulin hydrolysis generated primarily fructose with no oligomeric 17 
intermediate released.  These observations suggested that the β-fructosidases 18 
hydrolyzed the substrates in an exo-type fashion. 19 
Catabolite repression of FOS utilization by glucose.  Previous microarray 20 
expression analyses suggested that the expression of FOS-induced genes in L. 21 
paracasei 1195 was subject to catabolite repression by glucose (14).  To further assess 22 
the effect of glucose on FOS utilization, growth of cells in SDM containing both glucose 23 
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and FOS (0.1% and 0.35%, respectively) was compared to cells grown in SDM 1 
supplemented with either 0.1% glucose or 0.35% FOS.  A typical diauxic growth pattern 2 
was observed during growth on glucose plus FOS (Fig. 2).  The diauxic lag was likely 3 
caused by the depletion of glucose, since cessation of growth was also observed at a 4 
similar time and cell density for cells grown separately on the same amount of glucose.  5 
After the diauxic lag phase, cells resumed growth and entered a second growth phase 6 
using FOS as the carbon source, with the culture ultimately reaching approximately 7 
similar cell density that was achieved for cells grown on 0.35% FOS alone (i.e., about 8 
1.5).  Sugar analyses of the culture supernatants revealed that FOS was utilized only 9 
after glucose was consumed, confirming that glucose was metabolized preferentially 10 
(Fig. 3A).  When cells entered the second growth phase, GF4 and GF3 were rapidly 11 
hydrolyzed, resulting in a transient increase in the GF2 concentration.  Subsequently, 12 
the GF2 concentration gradually decreased to an undetectable level, with a 13 
simultaneous increase in the concentrations of glucose and sucrose (data not shown) 14 
from the hydrolysis of GF2. 15 
  To examine the kinetics of transcription of the fos operon during the diauxic shift, 16 
northern blot analysis, using a fosE probe, was performed on RNA samples obtained 17 
from cells grown on 0.1% glucose plus 0.35% FOS.  As expected, no hybridization 18 
signal for the fos genes was detected during the first growth phase when glucose was 19 
utilized as the preferred carbon source (Fig. 3B and 3C).  Shortly after the onset of the 20 
diauxic lag phase, the signal intensity associated with fosE gradually increased, with 21 
maximum transcript levels observed during the period when GF4 and GF3 were actively 22 
hydrolyzed (Fig. 3A).  This was followed by a dramatic reduction in the fosABCDXE 23 
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mRNA level as the GF4 and GF3 were depleted, along with a slight increase in the 1 
glucose concentration.  A second induction of the fos mRNA transcript was then 2 
observed (Fig. 3C, lane 14), coinciding with a decrease in the GF2 concentration.  3 
During the next few hours, the signal intensity of the fos operon decreased to an 4 
undetectable level (Fig. 3C, lanes 15 to 17).  This time frame is associated with the 5 
depletion of GF2 and an increase in glucose and sucrose levels in the culture 6 
supernatant.   7 
Expression of the fosE gene in L. rhamnosus GG.  In a previous study it was 8 
reported that L. rhamnosus GG, a widely used probiotic strain, was unable to utilize 9 
FOS as an energy source (21).  However, this strain is able to ferment fructose, 10 
indicating the presence of at least one fructose transport system.  Thus, only the fosE 11 
gene from the fos operon was introduced into the GG strain.  To construct a 12 
recombinant GG strain capable of metabolizing FOS, the fosE gene, along with its RBS, 13 
and the P-GL1 promoter sequence from L. rhamnosus GG (33) were cloned into the 14 
pTRKH2 shuttle vector (see Materials and Methods).  The resulting construct, pYG582, 15 
was transformed into the GG strain.  Unlike the parent strain, the recombinant GGE582 16 
strain harboring the pYG582 was able to utilize FOS for growth (Fig. 4).  In addition, the 17 
GGE582 strain gained the ability to grow in mMRS medium containing sucrose, inulin, 18 
and levan.  None of these sugars supported the growth of the parent strain. 19 
 20 
DISCUSSION 21 
Recent microarray transcriptome analyses of L. paracasei revealed the presence 22 
of an FOS metabolic pathway, encoded by the fosABCDXE operon, that was comprised 23 
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of a putative cell wall-associated β-fructosidase and a fructose/mannose PTS (14).  1 
Expression of the fos genes was induced by FOS and repressed in the presence of 2 
glucose.  Previous studies of FOS metabolism in L. paracasei 1195, however, had 3 
suggested that FOS uptake and hydrolysis were mediated by an ABC transport system 4 
and a cytoplasmic β-fructofuranosidase, respectively (22).  The cytoplasmic location of 5 
the FOS hydrolyzing enzyme, was based, in part, on the absence of activity in the 6 
supernatant, and also on the presence of activity associated with the crude cytoplasmic 7 
fraction.  In this report, the intracellular as well as the cell wall fractions were both 8 
examined, and β-fructosidase assays showed that the FOS hydrolysis activity was 9 
present primarily in the cell wall extract.  This fraction had very high activity and had not 10 
previously been assayed for β-fructosidase activity.  No cytoplasmic-specific LDH 11 
activity was detected in the culture supernatant or in the cell wall fraction.  These results 12 
indicate that cell lysis was minimal when the cultures were harvested prior to cell 13 
fractionation and also that the location of the β-fructosidase activity was distinct from the 14 
LDH activity.  These data provide evidence that FosE is a cell wall-associated β-15 
fructosidase, that, like other enzymes possessing LPXTG anchor motifs, faces the 16 
extracellular side of the cell wall and therefore, catalyzes FOS hydrolysis extracellularly 17 
(2, 25).  The anchoring of the FosE to the cell wall is likely mediated by the action of a 18 
sortase that cleaves between the alanyl and glycyl residues of the LPQAG motif, and 19 
subsequently catalyzes the formation of amide-linkage of the alanyl residue to the 20 
peptide crossbridge in the peptidoglycan layer (37).  The resulting 1,303-amino acid 21 
residue of the mature anchored β-fructosidase thus has an estimated molecular weight 22 
of 139 kDa. 23 
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The essential role of FosE in the FOS utilization pathway was demonstrated 1 
previously, when it was reported that insertional inactivation of fosE gene severely 2 
impaired the ability of the L. paracasei BHe mutant to grow on FOS (14).  In the present 3 
study, no β-fructosidase activity was detected from the cell wall extract of the BHe 4 
mutant.  In addition, the mutation prevented the utilization of FOS (FFn type), inulin, 5 
levan, and sucrose as sole carbon source, indicating that the fos operon is essential for 6 
metabolism of not only FOS and but also other fructose-containing carbohydrates. 7 
Expression of the β-fructosidase was induced during growth on FOS, inulin, and 8 
to a lesser extent, sucrose and fructose, but not on glucose.  Similarly, the preferred 9 
substrates were FOS of the FFn and GFn form, followed by inulin, with minor activity 10 
towards sucrose.  These results indicate that this enzyme may have preference for 11 
oligosaccharides having β-2,1-linkages.  The FFn form of FOS is composed of ca. 75% 12 
of fructose oligomers with a degree of polymerization of 2 to 10 and which do not 13 
contain a terminal glucose molecule.  Thus, most of the FOS chains have more fructosyl 14 
units per oligomer as substrates for successive exo-hydrolysis by β-fructosidase 15 
compared to the GFn form of FOS.  The low activity against the α-1,2 glucose-fructose 16 
bond in GFn, as indicated by the near absence of free glucose in reaction mixtures, 17 
would also explain why sucrose was not hydrolyzed.  Furthermore, the lower activities 18 
observed for inulin also indicate a preference for intermediate short chain length 19 
oligosaccharides.  The exo-hydrolysis activity of the β-fructosidase is supported by the 20 
observation that hydrolysis of the GF4 and GF3 fractions in FOS occurred first, 21 
producing GF2, sucrose, and fructose.  The latter two then accumulated gradually as the 22 
concentration of GF2 decreased.  Finally, that no growth was observed on raffinose, a 23 
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trisaccharide composed of galactose, glucose, and fructose, implies that raffinose is not 1 
a substrate for the β-fructosidase (data not shown). 2 
The diauxic growth pattern exhibited by L. paracasei 1195 grown on FOS in the 3 
presence of limiting glucose demonstrated that FOS utilization is subject to catabolite 4 
repression by glucose.  This observation was consistent with the results from 5 
transcriptome experiments showing that glucose repressed the transcription of FOS-6 
induced genes (14).  During growth on limiting glucose plus FOS, glucose was 7 
consumed first, although the cells had been sub-cultured in medium containing FOS.  8 
After the diauxic lag period, FOS was utilized in the order of GF4, GF3, and GF2, 9 
presumably due to the substrate preferences of FosE.  Interestingly, Northern 10 
hybridization analysis revealed that the expression of the fos genes was not constant 11 
during the post-diauxie secondary growth phase.  Rather, repression of the fos operon 12 
also occurred during the second growth phase.  While a small amount of glucose was 13 
generated from the hydrolysis of FOS, which may have contributed to the decreased 14 
transcript level of the fos mRNA, it also appears that the repression effect was not 15 
sufficient to cause a second diauxic lag. 16 
Although the molecular basis of regulation of the fos operon expression was not 17 
examined in detail during the present study, given the similarity in operon structure, the 18 
transcription of fos in L. paracasei 1195 is likely controlled by similar regulatory 19 
mechanisms as described for the lev operons in L. casei BL23 and Bacillus subtilis (27-20 
32).  However, unlike the lev operon of B. subtilis, transcriptional activation of the lev-21 
PTS in L. casei BL23 and the fos operon by LevR and FosR, respectively, are 22 
independent of a σ54-like sigma factor, since no -12, -24 promoter sequence 23 
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(CTGGCACN5TTGCA) was found in regions preceding both the BL23 lev operon and 1 
the fos operon (7, 8, 32).  In BL23, the activity of LevR is regulated by dual PTS-2 
catalyzed phosphorylation at conserved histidine residues in the EIIA and PRD2 3 
domains by P∼His-HPr and P∼His-EIIBLev, respectively (32).  In the presence of 4 
substrate for Lev-PTS, P∼His-EIIBLev preferably donates its phosphoryl group to the 5 
transported sugar, leading to dephosphorylation of LevR at His-776 by P∼His-EIIBLev 6 
and LevR activation, and thereby induction of the lev-PTS.  On the other hand, when 7 
metabolically preferred PTS sugars are present, such as glucose, the phosphoryl group 8 
of P∼His-HPr is used for sugar phosphorylation.  Poor phosphorylation at His-488 by 9 
P∼His-HPr renders LevR less active and down regulates expression of lev-PTS.  10 
Therefore, the lev operon is subject to carbon catabolite repression (CCR) by P∼His-11 
HPr dephosphorylation via LevR.  The presence of a putative cre sequence overlapping 12 
the transcriptional start site of the lev operon of BL23 (32) and the fos operon indicated 13 
that the expression of both operons are also controlled by CCR via binding of catabolite 14 
control protein CcpA to the cre site (14, 32).  In B. subtilis, accumulation of glycolytic 15 
intermediates, such as fructose-1,6-bisphosphosphate (FBP) from uptake of rapidly 16 
metabolizable sugars was proposed to stimulate the phosphorylation of HPr by HPr 17 
kinase (HprK) at Ser-46 (29).  P∼Ser-HPr acts as a co-repressor by interacting with 18 
CcpA, enabling CcpA to bind to cre and prevents transcription of the lev operon. 19 
Although certain strains of Lactobacillus are widely used as probiotics due to 20 
their various desirable traits (24), their ability to utilize prebiotic oligosaccharides, such 21 
as FOS, may be limited (21).  We have shown that the introduction of the fosE gene into 22 
the non-FOS-fermenting L. rhamnosus GG not only conferred on the recombinant 23 
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GGE582 strain the ability to utilize both forms of FOS efficiently, but also other 1 
prebiotics such as inulin and levan.  Although β-fructosidase activity was not measured 2 
in the FOS-fermenting transformant, this strain appeared to grow on these fructans as 3 
well as on glucose and fructose.  This demonstrates the feasibility of developing novel 4 
probiotic strains having enhanced metabolic functionality. 5 
In contrast to our findings that L. paracasei 1195 could grow on both forms of 6 
FOS, Saulnier et al. (43) recently reported that L. plantarum WCF1 was unable to grow 7 
on the FFn form.  Although L. plantarum WCF1 also possesses a putative β-8 
fructofuranosidase, this enzyme is apparently intracellular and is part of a sucrose 9 
transport and metabolic system.  The authors suggest that the small GFn 10 
oligosaccharides are transported via this sucrose system in L. plantarum WCF1.  This 11 
strain also had preference for GF2 and GF3, with relatively little consumption of GF4.  12 
Although L. paracasei 1195 was originally reported to have a similar substrate 13 
preference (21), the current data indicates that all of the FOS fractions, including GF4 14 
were metabolized by this strain. 15 
 Another related strain, Lactobacillus paracasei subsp. paracasei 8700:2 was also 16 
reported to use short and long chain fractions of FFn FOS, simultaneously, although 17 
when grown on inulin and FOS, the FFn chains were preferred (26).  Fructose, as well 18 
as sucrose and various FFn and GFn oligosaccharides, were also formed during growth 19 
on FOS and inulin, indicating that an enzyme capable of extracellular hydrolysis is 20 
present in this organism. 21 
Overall, results from this study and previous mutational analysis of the fosE gene 22 
(14) have provided evidence that the fos operon encodes key components for the 23 
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utilization of FOS and other structurally similar carbohydrates by L. paracasei 1195.  1 
While the cell wall-anchored FosE of the fos system may provide versatility in the 2 
utilization of larger prebiotic substrates without dependence on dedicated transporters 3 
for uptake of the substrates, it may also promote cross-feeding by providing access of 4 
the hydrolysis products to other intestinal microorganisms that do not possess a FOS 5 
metabolic pathway.  In addition, the results show that glucose, generated from 6 
hydrolysis of FOS or other glucose-containing polysaccharides, may catabolite repress, 7 
at least transiently, FOS metabolism in the GI environment.  Collectively, these results 8 
emphasize that understanding the mechanisms and regulation of prebiotic sugar 9 
utilization by probiotic bacteria and targeted commensals is necessary for rational 10 
selection and development of effective probiotics and prebiotics. 11 
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FIGURE LEGENDS 12 
 13 
Figure 1.  Induction and substrate specificities of β-fructosidases in cell wall extracts of 14 
L. paracasei 1195. 15 
 16 
Figure 2.  Growth of L. paracasei 1195 in SDM supplemented with 0.1% glucose (), 17 
0.35% FOS (∆), or 0.1% glucose plus 0.35% FOS (•). 18 
 19 
Figure 3.  Sugar utilization and fos operon expression during diauxic growth of L. 20 
paracasei 1195.  Cells were grown in SDM (A) containing 0.1% glucose plus 0.35% 21 
FOS.  Cell densities (•) and the concentrations of glucose (o), GF4 (∆), GF3 (X), and 22 
GF2 () present in the culture supernatant were determined.  In a parallel experiment, 23 
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cells were grown in the same medium (B), and Northern analysis of the fosABCDXE 1 
mRNA transcript levels (C), relative to the cell density (•) and glucose concentration (o) 2 
in the culture supernatant were determined.  Numbers labeled on the growth curves 3 
correspond to the lane numbers on the Northern blot indicating the time points at which 4 
cells were collected. 5 
 6 
Figure 4.  Growth of L. rhamnosus GG wild type (A) and GGE582 recombinant strain (B) 7 
in mMRS only (no CHO), or mMRS supplemented with 1% sugars or 0.5% levan, with 5 8 
µg/ml of Erm added into each growth medium for GGE582 strain.  All cultures were 9 
inoculated to an initial OD625nm of ∼ 0.02 to 0.05 and grown at 37°C in ambient 10 
atmosphere under static conditions of growth.  11 
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TABLE 1.  Bacterial strains, plasmids, and primers used in this study 
 
 
 
Genotype or characteristics 
 
Source or 
reference 
 
 
Strains 
  
   L. paracasei   
       1195 Parent strain, FOS-fermenter UNL 
collectiona 
       BHe 1195 isogenic strain with fosE gene disrupted by 
insertion inactivation  
14 
   
   L. rhamnosus    
       GG Parent strain, non-FOS-fermenter ConAgrab 
       GGE582 GG harboring pYG582 This study 
   
   E. coli   
       DH5α F- φ80dlacZ∆M15 ∆(lacZYA-argF)U169 deoR endA1 
recA1 hsdR17(rK- mK+) phoA supE44 λ- thi-1 gyrA96 
relA1 
Gibco-BRLc 
   
Plasmids   
   pTRKH2 High copy number shuttle cloning vector, P15A ori, 
pAMβ1 ori, Ermr, lacZ’ 
38 
   pRH5 pTRKH2 with fosE gene cloned into XhoI/PstI sites This study 
   pYG582 
 
pRH5 with P-GL1 promoter and fosE RBS cloned 
upstream of fosE 
This study 
   
Primers Sequence (5’ to 3’)d This study 
   fosE-for1 TGGCTTAGGAAAAGACGCCA  
   fosE-rev1 TGATCATCAGATACTCGCAA  
   fosE-for2 CGGACCTCGAGTTGGAAATGGATGAAAAGAAAC  
   fosE-rev2 ATTATCTGCAGTTAGACTCGCTTCACCCGCCTC  
   PGL1-for ATCAATGATATCACGGTTTTAAAATGAGCGTTG  
   PGL1-rev GCTACCTCGAGtcatcctccAACTTATTATGTTAATAA  
   
aUniversity of Nebraska Department of Food Science and Technology Culture Collection, 
Lincoln, NE. 
bConAgra Foods Inc., Omaha, NE. 
cGibco-BRL, Rockville, MD.  
drestriction enzyme sites, underlined; ribosomal binding site, lower case in bold. 
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TABLE 2.  FOS hydrolysis activities from culture supernatants and cell extracts of L. 
paracasei 1195 wild type and BHe mutant strain previously grown on mMRS containing 
1% FOS. 
 
                     Fructose released  
(nmoles/min/mg protein) 
 
L. paracasei 1195  
 
  culture supernatant                                     4 
  cell wall extract 3,400 
  cytoplasmic extract     13 
  
L. paracasei BHe  
  culture supernatant   0.2 
  cell wall extract                                  nda 
  cytoplasmic extract 
 
  nd 
a nd , none detected 
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ACC
EPT
ED
0.01
0.1
1
10
0 2 4 6 8 10 12 14 16 18 20
Time (hr)
O
D
 
a
t 6
25
 
n
m
Figure 2. Goh et al.
ACC
EPT
ED
Figure 3. Goh et al.
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Figure 4. Goh et al.
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